Sort
48,018 grants matching “immunotherapy”
Mechanisms of Clinical Reactivity or Tolerance to Mouse Allergen
$825,373Wayne G Shreffler · Massachusetts General Hospital · R01 · FY2010 · AI
The Role of Host Factors in HIV Immunopathogenesis
$825,308Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
IMPROVING THE DURABILITY OF IMMUNOLOGICAL MEMORY DURING ANTI-PD-1 IMMUNOTHERAPY
$825,247President And Fellows Of Harvard College · · FY2022 · Department of the Army
Novel Approaches to CD33-Directed Radioimmunotherapy
$825,157Roland Bruno Walter · Fred Hutchinson Cancer Center · R37 · FY2024 · CA
Fluorescent nanofoldamers for multiplex flow cytometry
$825,109Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2022 · GM
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
$825,019James R. Heath · Institute For Systems Biology · U54 · FY2022 · CA
Novel Interventions Against HPV-associated Neoplasia
$825,000Paul F Lambert · University Of Wisconsin-Madison · U01 · FY2009 · CA
Comprehensive antigenic mapping of the human anti-peanut IgE antibody response
$824,999Scott Alan Smith · Vanderbilt University Medical Center · R01 · FY2021 · AI
Clinical Fellowship Training Program
$824,926Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2021 · CA
Pathogenesis of Hepatitis B Virus in Transgenic Mice
$824,562Francis Vincent Chisari · Scripps Research Institute, The · R01 · FY2010 · CA
Control of Cytokine Gene Expression in LymphoidMyeloid Cells
$824,556Howard Young · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes
$824,415Michael S Kuhns · University Of Arizona · R01 · FY2025 · DK
T-PHARMACYTES FOR PROSTATE CANCER IMMUNOTHERAPY
$824,347Massachusetts Institute Of Technology · · FY2010 · Department of Defense
Understanding formation and dynamics of the SIV reservoir.
$824,331James Burton Whitney · Boston College · R56 · FY2025 · AI
Proteogenomic translator for cancer biomarker discovery towards precision medicine
$824,077Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2023 · CA
Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina
$824,043Maya Koronyo-Hamaoui · Cedars-Sinai Medical Center · R01 · FY2024 · AG
UNIVERSITY OF P.R PEDIATRIC AIDS CLINICAL TRIALS UNIT
$824,002University Of Puerto Rico Med Sciences · U01 · FY2003 · AI
Missouri Valley Cancer Consortium CCOP
$823,998Missouri Valley Cancer Consortium, Inc. · U10 · FY2004 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$823,919Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
$823,919Luke O. Russell · Vyriad, Inc. · R44 · FY2020 · CA
Biostatistics Shared Resources Core
$823,501Motomi Mori · St. Jude Children'S Research Hospital · P30 · FY2025 · CA
Clinical production of viral vectors for cancer gene therapy
$823,336Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Shared Resource: Comparative Medicine
$823,245Gordon Roble · Fred Hutchinson Cancer Research Center · P30 · FY2020 · CA
Specific Adoptive Immunotherapy of AML with Engineered CD8+ T Cells
$823,013Philip D Greenberg · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Examining IgG4 sialylation as a gain of function post-translation modification in IgG4-related diseases
$822,968Robert McCullough Anthony · Massachusetts General Hospital · R01 · FY2023 · AI